| |
TRENDS
Prescription Drugs And The Changing Patterns Of Treatment For Mental Disorders, 19962001
Samuel H. Zuvekas
This paper uses detailed data on prescription drug and other services from the Medical Expenditure Panel Survey (MEPS) to examine recent trends in mental health and substance abuse (MH/SA) treatment between 1996 and 2001. While use of ambulatory services remained constant, prescription drug use increased rapidly, with the result that 5.5 million more Americans received treatment in 2001. Prescription drug spending increased at a real rate of almost 20 percent a year. About one-third of this increase came from more MH/SA medication users and two-thirds from higher costs per user.

What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. H. Zuvekas and C. D. Meyerhoefer
State Variations In The Out-Of-Pocket Spending Burden For Outpatient Mental Health Treatment
Health Aff.,
May 1, 2009;
28(3):
713 - 722.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Levit, C. A. Kassed, R. M. Coffey, T. L. Mark, E. M. Stranges, J. A. Buck, and R. Vandivort-Warren
Future Funding For Mental Health And Substance Abuse: Increasing Burdens For The Public Sector
Health Aff.,
November 1, 2008;
27(6):
w513 - w522.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. Gonzalez, T. Croghan, B. West, D. Williams, R. Nesse, W. Tarraf, R. Taylor, L. Hinton, H. Neighbors, and J. Jackson
Antidepressant Use in Black and White Populations in the United States
Psychiatr Serv,
October 1, 2008;
59(10):
1131 - 1138.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Donohue and R. G. Frank
Estimating Medicare Part D's Impact on Medication Access Among Dually Eligible Beneficiaries With Mental Disorders
Psychiatr Serv,
October 1, 2007;
58(10):
1285 - 1291.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Mark, K. R. Levit, J. A. Buck, R. M. Coffey, and R. Vandivort-Warren
Mental Health Treatment Expenditure Trends, 1986 2003
Psychiatr Serv,
August 1, 2007;
58(8):
1041 - 1048.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Polinski, P. S. Wang, and M. A. Fischer
Medicaid's Prior Authorization Program And Access To Atypical Antipsychotic Medications
Health Aff.,
May 1, 2007;
26(3):
750 - 760.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. G. Druss
Rising mental health costs: what are we getting for our money?
Health Aff.,
May 1, 2006;
25(3):
614 - 622.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. A. Huskamp
Prices, profits, and innovation: examining criticisms of new psychotropic drugs' value.
Health Aff.,
May 1, 2006;
25(3):
635 - 646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Donohue
Mental health in the medicare part d drug benefit: a new regulatory model?
Health Aff.,
May 1, 2006;
25(3):
707 - 719.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. E. Morden and L. P. Garrison Jr.
Implications of part d for mentally ill dual eligibles: a challenge for medicare.
Health Aff.,
March 1, 2006;
25(2):
491 - 500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Zuvekas, A. E. Rupp, and G. S. Norquist
The Impacts Of Mental Health Parity And Managed Care In One Large Employer Group: A Reexamination
Health Aff.,
November 1, 2005;
24(6):
1668 - 1671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Rosenfeld, H. Kim, G. Londono, C. Kovner, and M. Mezey
Adult Ambulatory Care Visits to Nurses and Physicians: Methodological Limitations of the Medical Expenditure Panel Survey Data
Policy Politics Nursing Practice,
August 1, 2005;
6(3):
221 - 228.
[Abstract]
[PDF]
|
 |
|
|